BiPER Therapeutics is a startup based in France, most recent round Seed, 1 tracked investor.
BiPER Therapeutics is a company headquartered in France. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
BiPER Therapeutics develops first-in-class selective BiP inhibitors as targeted therapy for cancer patients, focusing on pushing cancer cells to burn out through unresolved ER stress induction.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.